Navigation Links
Fish Oil Promising Against Postpartum Depression in Small Trial
Date:4/12/2011

TUESDAY, April 12 (HealthDay News) -- Consuming omega-3 fatty acids in fish oil capsules during pregnancy may reduce a woman's risk of postpartum depression, according to a new study.

Researchers looked at 52 pregnant women who took either a placebo or a fish oil capsule containing 300 milligrams of docosahexaenoic acid (DHA) five days a week each week from weeks 24 to 40 of pregnancy. DHA is a prominent omega-3 fatty acid.

After the babies were born, the researchers assessed the women for postpartum depression symptoms, such as sleeping and eating problems, anxiety, emotional issues, confusion, guilt, loss of self and thoughts of suicide.

There weren't enough women in the study to determine if consuming DHA resulted in a lower incidence of postpartum depression. But women who took the fish oil capsules had significantly fewer symptoms of postpartum depression than those who took the placebo, said Dr. Michelle Price Judge, of the University of Connecticut School of Nursing, and colleagues.

"DHA consumption during pregnancy at levels that are reasonably attained from foods has the potential to decrease symptoms of postpartum depression," they concluded in a news release from the Federation of American Societies for Experimental Biology.

But one expert said the jury is still out on fish oil's ability to curb postpartum blues.

"This study is interesting but must be replicated on a larger scale with proper controls for a number of medical and psychosocial factors before concluding that omega-3 fatty acid consumption lowers the risk of postpartum depression," said Dr. Shari I. Lusskin, director of reproductive psychiatry at NYU Langone Medical Center in New York City.

"In the meanwhile," she said, "following a healthy diet can only be a good thing for the pregnant woman and her developing baby."

The study was to be presented Tuesday at a meeting of the federation in Washington, D.C. Research presented at meetings is considered preliminary until it is published in a peer-reviewed journal.

Postpartum depression affects up to 25 percent of new mothers, some experts estimate.

More information

The Nemours Foundation has more about postpartum depression.

-- Robert Preidt

SOURCE: Shari I. Lusskin, MD, director, reproductive psychiatry, NYU Langone Medical Center, New York City; Federation of the American Societies for Experimental Biology, news release, April 12, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. UCSF researchers identify promising new treatment for childhood leukemia
2. Mount Sinai finds promising clue to mechanism behind gene mutation that causes Parkinsons disease
3. Early success of anti-HIV preventive oral drug regimen is promising, but questions remain
4. K-State chemists work brings more national recognition as promising early-career scientist
5. Study yields promising results for patients with stroke
6. Washington Life Sciences Discovery Fund announces grants to commercialize promising technologies
7. UCSF tests promising solutions for cancer hair loss
8. Personalized molecular therapy shows promising results for people with advanced lung cancer
9. John Theurer Cancer Center presents studies on promising therapies for aggressive blood cancers
10. Less Invasive Lung Cancer Staging Looks Promising
11. New Blood Thinner a Promising Alternative to Warfarin
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Fish Oil Promising Against Postpartum Depression in Small Trial 
(Date:12/4/2016)... , ... December 03, 2016 , ... While James Earl ... serving as host for in a show called "Front Page". One of the forthcoming ... years, breast cancer rates have plummeted in large part due to early detection. Like ...
(Date:12/4/2016)... ... December 04, 2016 , ... Patients who wish to ... advantage of a cosmetic procedure known as Carbon Dioxide (C02) Fractional Laser ... of age spots, fine lines, uneven coloration, wrinkles, scarring, skin laxity or ...
(Date:12/2/2016)... ... December 02, 2016 , ... Lori G. Cohen and ... will speak at the American Conference Institute’s 21st Drug & Medical Device Litigation ... Lead Sponsor of the conference. , Cohen, who chairs the firm’s Pharmaceutical, Medical Device ...
(Date:12/2/2016)... ... December 02, 2016 , ... More than 100 business, civic, ... to attend the UNCF Dothan-Wiregrass Mayor’s Luncheon Dec. 9, 2016. This inaugural event, ... and operating support to UNCF-member institutions, including Miles College, Oakwood University, Tuskegee University, ...
(Date:12/2/2016)... ... , ... The annual time frame to change Medicare health and prescription drug ... 7th. Currently-enrolled Medicare beneficiaries who are looking to switch from their current plan to ... make changes during this period order for their new policy to go into effect ...
Breaking Medicine News(10 mins):
(Date:12/4/2016)... 2016  Results from the Phase II SUSTAIN study ... reduced the median annual rate of sickle cell-related pain ... 2.98, p=0.010) in patients with or without hydroxyurea therapy ... being featured in the official press briefing at the ... Meeting and presented during the Plenary Scientific Session tomorrow ...
(Date:12/2/2016)... December 2, 2016 - bioLytical lanza el INSTI HIV ... la OMS     Continue Reading ... ... , , bioLytical ... anunciado hoy que está expandiendo el lanzamiento de su INSTI HIV Self Test ...
(Date:12/2/2016)... December 2, 2016 According to the ... Market Study on Automated Endoscope Reprocessors: Single Basin Automated Endoscope ... 8.6% Between 2016 and 2024 " the global automated endoscope reprocessors market was ... to expand at a CAGR of 7.2% during an eight-year ... 1,367.6 Mn by 2024. ...
Breaking Medicine Technology: